help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 1, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2003-032029
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/4/2097    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piaditis, G.
Right arrow Articles by Kovacs, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piaditis, G.
Right arrow Articles by Kovacs, K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Ovarian Cancer
*Pancreatic Cancer

Submitted on November 20, 2003
Accepted on December 6, 2004

ECTOPIC BIOACTIVE LUTEINIZING HORMONE SECRETION BY A PANCREATIC ENDOCRINE TUMOR MANIFESTED AS LUTEINIZED GRANULOSA-THECA CELL TUMOR OF THE OVARIES

G. Piaditis*, A. Angellou, G. Kontogeorgos, N. Mazarakis, Th. Kounadi, G. Kaltsas, K. Vamvakidis, R. V. Lloyd, E. Horvath, and K. Kovacs

Departments of Endocrinology & Diabetes, Pathologyand Surgery, G. Gennimatas General Hospital of Athens, Greece, Pathology and Laboratory Medicine, Mayo Clinic Foundation, Rochester MN and Pathology St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada

* To whom correspondence should be addressed. E-mail: edk-pgna{at}otenet.gr.

Endocrine pancreatic tumors are rare neoplasms consisting of multipotent cells capable of secreting various bioactive substances causing characteristic clinical syndromes. Ovarian stromal hyperthecosis is characterized by varying degrees of luteinized stromal cell proliferation following sustained LH and/or hCG stimulation, clinically manifested by symptoms/signs of virilization resembling the polycystic ovary syndrome (PCOS). We report a case of ectopic bioactive LH production from a pancreatic endocrine tumor in a 33-yr-old woman with rapidly developing symptoms/signs of hyperandrogenism and markedly elevated serum androgen and LH levels leading to hyperthecosis and bilateral luteinized granulosa-theca cell tumors of the ovaries. Although the patient was initially thought to have either severe PCOS or an LH-secreting pituitary tumor, an LH producing pancreatic endocrine tumor bearing somatostatin receptors was demonstrated on scintigraphy with 111In-octreotide and abdominal imaging. Symptoms and signs of hyperandrogenism resolved following the resection of the tumor. Immunohistochemistry, in situ hybridization and electron microscopy studies confirmed LH synthesis by the tumor cell. Although extremely rare, ectopic LH production from non-pituitary endocrine tumors should be considered in the differential diagnosis of hyperandrogenism particularly when associated with highly elevated serum LH levels.


Key words: Ectopic • bioactive • LH • endocrine • pancreas • tumor • hyperthecosis • luteoma







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society